Outcomes after total hip arthroplasty in young patients with osteonecrosis of the hip.

Autor:	Swarup I; Department of Orthopaedic Surgery, Hospital for Special Surgery, New York - USA., Shields M; Department of Orthopaedic Surgery, Hospital for Special Surgery, New York - USA., Mayer EN; David Geffen School of Medicine at UCLA, Los Angeles - USA., Hendow CJ; New York Medical College, Valhalla - USA., Burket JC; Healthcare Research Institute, Hospital for Special Surgery, New York - USA., Figgie MP; Department of Orthopaedic Surgery, Hospital for Special Surgery, New York - USA.
Jazyk:	angličtina
Zdroj:	Hip international : the journal of clinical and experimental research on hip pathology and therapy [Hip Int] 2017 May 12; Vol. 27 (3), pp. 286-292. Date of Electronic Publication: 2017 Jan 31.
DOI:	10.5301/hipint.5000457
Abstrakt:	Background: Osteonecrosis of the hip is a clinical, radiographic, and pathologic entity that commonly affects young patients. This study evaluates long-term implant survival and patient-reported outcomes after primary total hip arthroplasty (THA) in patients with osteonecrosis aged 35 or younger. Methods: A retrospective study with prospective follow-up was conducted at a major academic medical center. Chart review was performed to identify young THA patients with osteonecrosis, and follow-up surveys were conducted to determine implant survival and patient-reported outcomes. Kaplan-Meier survival analysis was performed to evaluate implant survival, and the hip disability and osteoarthritis outcome score (HOOS) was used to describe patient-reported outcomes. Results: The study included 135 patients (204 THAs) with a mean time to follow-up of 14 years. In this group, 10-year implant survival was 86% and 20-year implant survival was 66%. Implant survival was longer in male patients (p = 0.02) and patients that were over the age of 25 at the time of surgery (p = 0.03). The mean HOOS scores at follow-up were 87 for pain, symptoms, and ADLs, and 77 for sports. All HOOS measures were lower in patients that underwent a revision THA, and HOOS-Pain and HOOS-Sport scores were lower in patients that were over the age of 25 at the time of surgery (p<0.05). Conclusions: Young patients with osteonecrosis have good implant survival and long-term outcomes after THA. Patient factors and implant characteristics should be considered when predicting implant survival and outcomes after THA in young patients with osteonecrosis.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu